Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
Other (Supplementary Materials)
3MB |
Item Type: | Article |
---|---|
Title: | Tryptophan hydroxylase-2-mediated serotonin biosynthesis suppresses cell reprogramming into pluripotent state |
Creators Name: | Sinenko, S.A., Kuzmin, A.A., Skvortsova, E.V., Ponomartsev, S.V., Efimova, E.V., Bader, M., Alenina, N. and Tomilin, A.N. |
Abstract: | The monoamine neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) has important functions both in the neural system and during embryonic development in mammals. In this study, we set out to investigate whether and how endogenous serotonin affects reprogramming to pluripotency. As serotonin is synthesized from tryptophan by the rate limiting enzymes tryptophan hydroxylase-1 and -2 (TPH1 and TPH2), we have assessed the reprogramming of TPH1- and/or TPH2-deficient mouse embryonic fibroblasts (MEFs) to induced pluripotent stem cells (iPSCs). The reprogramming of the double mutant MEFs showed a dramatic increase in the efficiency of iPSC generation. In contrast, ectopic expression of TPH2 alone or in conjunction with TPH1 reverted the rate of reprogramming of the double mutant MEFs to the wild-type level and besides, TPH2 overexpression significantly suppressed reprogramming of wild-type MEFs. Our data thus suggest a negative role of serotonin biosynthesis in the reprogramming of somatic cells to a pluripotent state. |
Keywords: | Serotonin, 5-HT, Pluripotency, Reprogramming, Induced Pluripotent Stem Cells (iPSCs), Tryptophan Hydroxylase 1 and 2 (TPH1 and TPH2), Animals, Mice |
Source: | International Journal of Molecular Sciences |
ISSN: | 1422-0067 |
Publisher: | MDPI |
Volume: | 24 |
Number: | 5 |
Page Range: | 4862 |
Date: | 2 March 2023 |
Official Publication: | https://doi.org/10.3390/ijms24054862 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page